161 related articles for article (PubMed ID: 9453468)
1. Effects of TMK688, a novel anti-allergic drug, on allergic nasal obstruction and exudative responses in sensitized guinea pigs.
Shizawa T; Maeda K; Abe K; Ishii T; Kamitani T
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):815-9. PubMed ID: 9453468
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of TMK688, a novel anti-allergic drug having both 5-lipoxygenase inhibitory activity and anti-histamine activity, against bronchoconstriction, leukotriene production and inflammatory cell infiltration in sensitized guinea pigs.
Tohda Y; Nakajima S; Shizawa T; Maeda K; Ohmori S; Satoh H; Ishii T; Kamitani T
Clin Exp Allergy; 1997 Jan; 27(1):110-8. PubMed ID: 9117875
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of non-drowsiness after oral administration of TMK688, a novel antiallergic drug.
Shizawa T; Inaba K; Yoshida F; Iizuka T; Hijikuro K; Yanoshita R; Kamitani T
Arzneimittelforschung; 1998 Oct; 48(10):979-84. PubMed ID: 9825114
[TBL] [Abstract][Full Text] [Related]
4. 5-Lipoxygenase inhibitory and antihistamine activities of linetastine.
Shizawa T; Ohmori S; Maeda K; Sakata K; Ishii T; Kamitani T
Arzneimittelforschung; 1996 Nov; 46(11):1072-6. PubMed ID: 8955867
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory action of orally active 5-lipoxygenase inhibitor TMK688.
Yamamoto S; Jiang H; Kato R
Pharmacology; 1994 May; 48(5):273-82. PubMed ID: 8016188
[TBL] [Abstract][Full Text] [Related]
6. Involvement of thromboxane A2 and histamine in experimental allergic rhinitis of guinea pigs.
Yamasaki M; Matsumoto T; Fukuda S; Nakayama T; Nagaya H; Ashida Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1471-9. PubMed ID: 9067337
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of two-stage skin carcinogenesis as well as complete skin carcinogenesis by oral administration of TMK688, a potent lipoxygenase inhibitor.
Jiang H; Yamamoto S; Kato R
Carcinogenesis; 1994 May; 15(5):807-12. PubMed ID: 8200079
[TBL] [Abstract][Full Text] [Related]
8. Involvement of thromboxane A2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis.
Yamasaki M; Mizutani N; Sasaki K; Nabe T; Matsumoto T; Ashida Y; Kohno S
Inflamm Res; 2001 Sep; 50(9):466-73. PubMed ID: 11603852
[TBL] [Abstract][Full Text] [Related]
9. Effects of a specific cysteinyl leukotriene antagonist, pranlukast, on antigen-induced cysteinyl leukotriene-mediated rhinitis in guinea pigs.
Fujita M; Yonetomi Y; Takeda H; Nakagawa N; Kawabata K; Ohno H
Jpn J Pharmacol; 1997 Dec; 75(4):347-53. PubMed ID: 9469640
[TBL] [Abstract][Full Text] [Related]
10. Study on the dye leakage response of nasal mucosa following topical, capsaicin challenge in guinea pigs.
Asakura K; Shirasaki H; Narita S; Kojima T; Kataura A
Acta Otolaryngol; 1992; 112(3):545-51. PubMed ID: 1279930
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis.
Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X
Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271
[TBL] [Abstract][Full Text] [Related]
12. [Effect of betotastine besilate (TAU-284), a novel anti-allergic agent, on experimental allergic rhinitis].
Murata T; Matsumoto Y; Suzuki T; Naito K; Takata I; Tsuzurahara K
Arerugi; 1997 Jul; 46(7):576-84. PubMed ID: 9301130
[TBL] [Abstract][Full Text] [Related]
13. Effects of TAK-427 on acute nasal symptoms and nasal obstruction in guinea pig model of experimental allergic rhinitis.
Fukuda S; Midoro K; Gyoten M; Kawano Y; Ashida Y; Nabe T; Kohno S; Nagaya H
Eur J Pharmacol; 2003 Aug; 476(3):239-47. PubMed ID: 12969771
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor (PAF)-induced rhinitis and involvement of PAF in allergic rhinitis in guinea pigs.
Misawa M; Iwamura S
Jpn J Pharmacol; 1990 Oct; 54(2):217-26. PubMed ID: 2077186
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of TMK688 on skin tumor initiation caused by 7,12-dimethylbenz[a]anthracene in relation to inhibition of aryl hydrocarbon hydroxylase activity and Cyp1a1 mRNA induction.
Jiang H; Yamamoto S; Ozawa S; Shimada M; Yamazoe Y; Kato R
Pharmacology; 1996 Aug; 53(2):123-32. PubMed ID: 8902877
[TBL] [Abstract][Full Text] [Related]
16. Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen.
Ueno M; Inagaki N; Nagai H; Koda A
Pharmacology; 1998 Oct; 57(4):206-14. PubMed ID: 9730778
[TBL] [Abstract][Full Text] [Related]
17. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects.
Matsushita N; Aritake K; Takada A; Hizue M; Hayashi K; Mitsui K; Hayashi M; Hirotsu I; Kimura Y; Tani T; Nakajima H
Jpn J Pharmacol; 1998 Sep; 78(1):11-22. PubMed ID: 9804057
[TBL] [Abstract][Full Text] [Related]
19. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades.
Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y
Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479
[TBL] [Abstract][Full Text] [Related]
20. Histamine H1 receptor and reactivity of the nasal mucosa in sensitized guinea pigs.
Ohkawa C; Ukai K; Miyahara Y; Takeuchi K; Sakakura Y
Auris Nasus Larynx; 1999 Jul; 26(3):293-8. PubMed ID: 10419037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
